Advanced search
Publication Cover
Human Fertility
an international, multidisciplinary journal dedicated to furthering research and promoting good practice
Volume 25, 2022 - Issue 5
Submit an article Journal homepage
296
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Changes in the T-helper 1 and 2 cell populations during pregnancy in tacrolimus-treated women with repeated implantation failure and recurrent pregnancy loss

Michi Hisanoa Center of Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development, Tokyo, JapanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-5679-2447
ORCID Icon,
Koji Nakagawab Center for Reproductive Medicine and Implantation Research, Sugiyama Clinic Shinjuku, Tokyo, Japan
,
Joanne Kwak-Kimc Reproductive Medicine, Department of Obstetrics and Gynecology, Chicago Medical School at Rosalind Franklin University of Medicine and Science, Vernon Hills, IL, USA
,
Rikikazu Sugiyamab Center for Reproductive Medicine and Implantation Research, Sugiyama Clinic Shinjuku, Tokyo, Japan
,
Haruhiko Sagoa Center of Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development, Tokyo, Japan
&
Koushi Yamaguchia Center of Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development, Tokyo, Japan
Pages 975-982 | Received 02 Oct 2020, Accepted 12 May 2021, Published online: 24 Jul 2021

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Michi Hisano, Koji Nakagawa, Tomo Suzuki, Rikikazu Sugiyama & Koushi Yamaguchi. (2023) Immunosuppressive therapy with tacrolimus is a potential drug candidate for the prevention of unexplained or preeclamptic stillbirths with Th1-dominant immune states: a case series of five patients. The Journal of Maternal-Fetal & Neonatal Medicine 36:2.
Read now

Articles from other publishers (8)

Marcelo Borges Cavalcante, Ana Clara Muniz Tavares, Camila Alves Rocha, Giselle Ferreira de Souza, Eduarda Maia Lima, Júlia Machado Luz Simões, Larissa Cruz de Souza, Maria Yzadora Moura Martins, Nicole Oliveira de Araújo & Ricardo Barini. (2023) Calcineurin inhibitors in the management of recurrent miscarriage and recurrent implantation failure: Systematic review and meta-analysis. Journal of Reproductive Immunology 160, pages 104157.
Crossref
Michi Hisano, Koji Nakagawa, Masanori Ono, Osamu Yoshino, Takakazu Saito, Yasushi Hirota, Eisuke Inoue, Kayoko Kikuchi, Hidefumi NakamuraKoushi Yamaguchi. (2023) Multicenter, 2-dose single-group controlled trial of tacrolimus for the severe infertility patients. Medicine 102:32, pages e34317.
Crossref
Julia Tomkiewicz & Dorota Darmochwał-Kolarz. (2023) The Diagnostics and Treatment of Recurrent Pregnancy Loss. Journal of Clinical Medicine 12:14, pages 4768.
Crossref
Mihaela Andreescu. (2023) The impact of the use of immunosuppressive treatment after an embryo transfer in increasing the rate of live birth. Frontiers in Medicine 10.
Crossref
Samaneh Abdolmohammadi-Vahid, Leili Aghebati-Maleki, Javad Ahmadian-Heris, Shahla Danaii & Mehdi Yousefi. 2023. IVF Technologies and Infertility - Current Practices and New Perspectives. IVF Technologies and Infertility - Current Practices and New Perspectives.
Ping Shen, Tao Zhang, Ru Han, Huixia Xie & Qun Lv. (2022) Co‐administration of tacrolimus and low molecular weight heparin in patients with a history of implantation failure and elevated peripheral blood natural killer cell proportion. Journal of Obstetrics and Gynaecology Research 49:2, pages 649-657.
Crossref
Nupur Mukherjee, Richa Sharma & Deepak Modi. (2022) Immune alterations in recurrent implantation failure. American Journal of Reproductive Immunology 89:2.
Crossref
Qian Zhou, Weifan Yin, Jiahao Zhu, Weiwei Duan, Yi Li, Wanlin Jin & Huan Yang. (2022) Risk factors associated with adverse pregnancy outcomes and postpartum exacerbation in women with myasthenia gravis. American Journal of Reproductive Immunology 88:6.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.